Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Abbott Laboratories (NYSE:ABT) reported its Q3 2024 earnings, meeting EPS expectations while slightly missing revenue forecasts. The company posted an EPS of $1.34, aligning with analysts' predictions ...